Cure Today22h
Treatment Discontinuations Reduced With Jaypirca in CLL, SLL
Jaypirca showed superior progression-free survival and lower discontinuation rates versus standard treatments in patients ...
Cure Today21h
Camizestrant Plus Kisqali May Be Safe, Effective in ER+/HER2- Breast Cancer
Among patients with ER-positive/HER2-negative advanced breast cancer, treatment with camizestrant in combination with Kisqali ...
Cure Today15h
Local Recurrence Lowered With Immediate Surgery in Elderly Patients With Breast Cancer
Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.
Cure Today16h
Lynparza Continues to Benefit in BRCA1/2+, HER2- Breast Cancer
Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.
Cure Today19h
With CLL, I Try to Make the Best of Everything
I haven’t been too happy with my blood work with CLL, but I try to enjoy what I can — including apples during fall.